SCHEMBL561840

SCHEMBL561840

CC1(C)NC(=O)C(C)(C)N1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467970 0.74 POLB (0.38) POLB
SCHEMBL14446948 0.73
SCHEMBL2999710 0.71 TSHR (0.31) POLB
SCHEMBL7957300 0.67
SCHEMBL4336485 0.66 SMN1; SMN2 (0.34)
SCHEMBL1874156 0.65
SCHEMBL17113508 0.64 NEK2 (0.35)
SCHEMBL11053126 0.64 HDAC1 (0.33)
SCHEMBL4558728 0.61 LMNA (0.38) POLB
SCHEMBL22069 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240374773-A1 COMPOSITION FOR THE PREVENTION AND ELIMINATION OF ODORS OXISCIENCE, LLC (US) 2024-11-14 US claimed
US-12042581-B2 Method for manufacturing a medium for purifying fluids containing toxic compounds OXISCIENCE, LLC (US) 2024-07-23 US claimed
CN-113197690-B Dental implant with hydrophilic antibacterial property 山东恒泰医疗器械有限公司 2022-03-01 CN claimed
CN-114106400-A Aziridine crosslinked N-halamine type antibacterial PVA sponge as well as preparation method and application thereof 江西省科学院应用化学研究所 2022-03-01 CN claimed
CN-113197690-A Dental implant with hydrophilic antibacterial property 山东恒泰医疗器械有限公司 2021-08-03 CN claimed
CN-113136270-A Plant type antibacterial cleaning agent and production process thereof 安徽达尔美生物科技有限公司 2021-07-20 CN claimed
US-20200339512-A1 POLYMERIZABLE COMPOUNDS WITH ONE OR MORE SURFACTANT-LIKE PROPERTIES EXIGENCE TECHNOLOGIES INC. (CA) 2020-10-29 US claimed
US-10721907-B2 Antimicrobial compositions and methods with novel polymeric binding system OXISCIENCE, LLC (US) 2020-07-28 US claimed
EP-3661916-A1 POLYMERIZABLE COMPOUNDS WITH ONE OR MORE SURFACTANT-LIKE PROPERTIES University of Manitoba (CA) 2020-06-10 EP claimed
WO-2019023798-A1 POLYMERIZABLE COMPOUNDS WITH ONE OR MORE SURFACTANT-LIKE PROPERTIES EXIGENCE TECHNOLOGIES INC. (CA) 2019-02-07 WO claimed
EP-0513239-A4 N,N'-DIHALOIMIDAZOLIDIN-4-ONES 1993-03-10 EP claimed
EP-0513239-A1 N,N'-DIHALOIMIDAZOLIDIN-4-ONES AUBURN UNIVERSITY (US) 1992-11-19 EP claimed
EP-0248494-B1 POLYMERIC STABILIZER COMPOUNDS AND PROCESS FOR THEIR PREPARATION ENIRICERCHE S.p.A. (IT) 1992-08-26 EP claimed
US-5126057-A Stabilizers against solar radiation AUBURN RESEARCH FOUNDATION (US) 1992-06-30 US claimed
WO-1991010623-A1 N,N'-DIHALOIMIDAZOLIDIN-4-ONES AUBURN UNIVERSITY (US) 1991-07-25 WO claimed
US-4853440-A ULTRAVIOLET RADIATION SCREENS FOR PROPYLENE ENIRICERCHE, S.P.A. (IT) 1989-08-01 US claimed
US-4797451-A VINYL AROMATIC, HINDERED POLYETHER OR DIENE-OLEFIN POLYMERS MODIFIED WITH HINDERED AMINES ENIRICERCHE S.P.A. (IT) 1989-01-10 US claimed
EP-0248494-A2 Polymeric stabilizer compounds and process for their preparation ENIRICERCHE S.p.A. (IT) 1987-12-09 EP claimed
EP-0218298-A2 Solid polymeric stabilizer compounds and process for their manufacturing ENIRICERCHE S.p.A. (IT) 1987-04-15 EP claimed
US-4448969-A Cyclic ether or carbonate alkylation products of 2,2,5,5-tetramethylimidazolidin-4-one and derivatives, their preparation, and their use as stabilizers for _synthetic polymers FERRO CORPORATION (US) 1984-05-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240374773-A1 COMPOSITION FOR THE PREVENTION AND ELIMINATION OF ODORS ABCB7, HEXB, MAOB POLB 101/4885
US-12042581-B2 Method for manufacturing a medium for purifying fluids containing toxic compounds NEFM, HTT, LPO POLB 625/4885
US-10721907-B2 Antimicrobial compositions and methods with novel polymeric binding system LPO, CUTA, MPO POLB 217/4885
US-20200339512-A1 POLYMERIZABLE COMPOUNDS WITH ONE OR MORE SURFACTANT-LIKE PROPERTIES SMPD1, SGMS1, SMPD4 POLB 1369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.